医学
持续气道正压
阻塞性睡眠呼吸暂停
麻醉
气道
气道正压
呼吸暂停
睡眠呼吸暂停
心脏病学
内科学
作者
Kun‐Ming Wu,Ching‐Chi Lin,Chung‐Hsin Chiu,Shwu‐Fang Liaw
出处
期刊:Chest
[Elsevier]
日期:2009-11-21
卷期号:137 (2): 303-309
被引量:22
标识
DOI:10.1378/chest.09-0936
摘要
Background Serum levels of high mobility group box-1 protein (HMGB1) are increased in a variety of inflammatory disorders. Obstructive sleep apnea syndrome (OSAS) is associated with inflammation secondary to chronic intermittent hypoxia, but HMGB1 levels in treated and untreated OSAS have not been evaluated. Methods Twenty healthy subjects and 30 subjects with moderately severe or severe OSAS who desired nasal continuous positive airway pressure (CPAP) treatment were enrolled. Serum levels of HMGB1 and nitric oxide derivative (NOx) from peripheral blood samples were measured, and all subjects underwent a sleep study. These studies were repeated 2 months after nasal CPAP treatment in the patients with OSAS. Results In OSAS before nasal CPAP treatment, the serum level of HMGB1 was higher but that of NOx was lower than those levels of normal subjects. The HMGB1 levels correlated negatively with NOx levels in subjects with OSAS. After nasal CPAP treatment, the HMGB1 and NOx returned to normal levels. Conclusion Elevated HMGB1 levels and reduced NOx levels in patients with OSAS normalized after nasal CPAP treatment. Serum levels of high mobility group box-1 protein (HMGB1) are increased in a variety of inflammatory disorders. Obstructive sleep apnea syndrome (OSAS) is associated with inflammation secondary to chronic intermittent hypoxia, but HMGB1 levels in treated and untreated OSAS have not been evaluated. Twenty healthy subjects and 30 subjects with moderately severe or severe OSAS who desired nasal continuous positive airway pressure (CPAP) treatment were enrolled. Serum levels of HMGB1 and nitric oxide derivative (NOx) from peripheral blood samples were measured, and all subjects underwent a sleep study. These studies were repeated 2 months after nasal CPAP treatment in the patients with OSAS. In OSAS before nasal CPAP treatment, the serum level of HMGB1 was higher but that of NOx was lower than those levels of normal subjects. The HMGB1 levels correlated negatively with NOx levels in subjects with OSAS. After nasal CPAP treatment, the HMGB1 and NOx returned to normal levels. Elevated HMGB1 levels and reduced NOx levels in patients with OSAS normalized after nasal CPAP treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI